Sofinnova Investments, Inc. Horizon Therapeutics Public LTD CO Transaction History

Sofinnova Investments, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $467,271 - $494,179	-4,354 Reduced 1.05%	408,819 $44.6 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $25.8 Million - $47 Million	413,173 New	413,173 $47 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $10.5 Million - $15.4 Million	-132,597 Reduced 56.93%	100,297 $8 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $959,434 - $1.22 Million	11,102 Added 5.01%	232,894 $24.5 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $6.34 Million - $7.71 Million	64,305 Added 40.83%	221,792 $23.9 Million

Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $14.5 Million - $17.4 Million	157,487 New	157,487 $17.3 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $11.6 Million - $12.9 Million	-133,997 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $5.7 Million - $7.58 Million	-79,393 Reduced 37.21%	133,997 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $14.3 Million - $18 Million	213,390 New	213,390 $15.6 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $14 Million - $20.2 Million	-252,958 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $7.64 Million - $14.4 Million	252,958 New	252,958 $14.1 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.